The stroma not only serves as a growth promoting source of signals but it is also a physical barrier to drug delivery.Understanding the tumor-stroma signaling leading to development of desmoplastic reaction and tumor progression can lead to the development of therapies to decrease stromal activity and improve drug delivery.In this review,we focus

on how the current understanding of biology of the pancreatic tumor microenvironment can be translated into the development of targeted therapy.
Pancreatic cancer is one of the most aggressive and difficult cancers to treat.Despite numerous research efforts,limited 没有 success has been achieved in the therapeutic management of patients with this disease.In the current review,we focus on one component of morphogenesis signaling,Hedgehog(Hh),with the aim of developing novel,effective therapies for the treatment of pancreatic cancer.Hh signaling contributes to the induction of a malignant phenotype in pancreatic cancer and is responsible for maintaining LBH589购买 pancreatic cancer stem cells.In addition,we propose a novel concept linking Hh signaling and tumor hypoxic

conditions,and discuss the

effects of Hh inhibitors in clinical trials.The Hh signaling pathway may represent a potential therapeutic target for patients with refractory pancreatic cancer.
乳腺癌是女性最常见的恶性肿瘤,病死率居全球首位。近20年,由于早期发现和辅助治疗的改进,乳腺癌的治疗疗效已明显提升,但很多患者仍面临复发的恐惧和死亡的威胁[1]。现阶段,乳腺癌总体复发率约40%,其中60%~70%的患者发生远处转移[2]。应用常规化疗药物联合治疗,HER-2阳性早期转移性乳腺癌对trastuzumab的反应率为50%~84%,但疗程开始1年内药物即对患者失效。目前,
髓母细胞瘤是发生于小脑的原始神经外胚层肿瘤,是恶性度最高的神经上皮肿瘤之一。传统治疗主要包括肿瘤切除、放疗及化疗,但髓母细胞瘤侵袭性强,术后复发率高。Hedgehog是一高度保守的细胞信号通路,被认为是肿瘤治疗的一个重要靶点。研究证实该通路在髓母细胞瘤中异常活化,本文就Hedgehog通路靶向治疗髓母细胞瘤的研究进展进行综述。
Hedgehog(HH)信号通路在胚胎发育和器官形成中发挥重要作用。当该通路中成员发生异常如patched(PTCH)发生缺失或突变,smoothened(SMO)发生突变,Gli异常扩增或者蛋白质稳定性增加等,都会导致该通路异常激活,并诱导如基底细胞癌、成神经管细胞瘤等癌症发生。因此阻断HH信号通路是应用于癌症治疗的一个有效手段。目前以HH信号通路不同成员为靶点已开发出多种HH信号通路小分子抑制剂,其中以HH信号通路上游成员为靶点的抑制剂最多。在今后的研究中,应该更加注重于以HH信号通路下游为靶点,开发更加有效的抗癌药物。
为了提高抗肿瘤药物vismodegib合成反应的产率并控制反应成本,制备了合成目标化合物所需的中间体,并对Negishi偶联反应条件进行了考察.通过单因素分析法,研究了不同的摩尔比、催化剂用量和回流时间对反应的影响.结果表明,在反应混合物2-溴吡啶、2-氯-N-(4-氯-3-碘苯基)-4-(甲磺酰)苯甲酰胺、氯化锌、正丁基锂和四(三苯基膦)钯的摩尔比为1.0∶0.5∶1.5∶1.1∶0.05及回流时间为24 很少 h的条件下,反应收率提高到了72%.该反应条件明显提高了合成效率,避免了原料/催化剂的过多消耗,同时避免了过长的反应时间.反应体系配比和反应时间的优化在合成vismodegib的过程中对提高效率和经济性有重要作用.